SURGE Therapeutics

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy deployment. The company provides an injectable biodegradable hydrogel that allows for the prolonged, localized release of most cancer immunotherapy at the site of surgical tumor resection by focusing the dose at the right place and right time.